<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shu J</submitter><funding>Training Program for Young and Middle-aged Health Science and TechnologyInnovation Leaders in Henan Province</funding><funding>2024 Key Scientific Research Programfor Higher Education Institutions in Henan Province</funding><funding>National Natural Science Foundation of China</funding><pagination>1092</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12599082</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(1)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Esophageal squamous cell carcinoma (ESCC) is a lethal malignancy with limited therapeutic options, primarily due to its aggressive metastatic behavior. This study aimed to elucidate the molecular drivers of ESCC metastasis by identifying a critical oncogene and investigate its functional mechanisms.&lt;h4>Methods&lt;/h4>Using integrated bioinformatics screening, we identified NDC80 as a potential regulator of metastasis. The role and underlying mechanisms of NDC80 in ESCC progression have remained to be fully elucidated. We conducted in vitro functional assays-including real-time PCR, western blotting, and flow cytometry-to assess the effects of NDC80 on epithelial-mesenchymal transition (EMT) and malignant behavior. Mechanistic studies such as co-culture systems and ELISA, wer</pubmed_abstract><journal>European journal of medical research</journal><pubmed_title>NDC80 promotes epithelial to mesenchymal transition of esophageal squamous cell carcinoma through macrophages polarization and PI3K/AKT pathway activation.</pubmed_title><pmcid>PMC12599082</pmcid><funding_grant_id>YXKC2022015</funding_grant_id><funding_grant_id>82070222</funding_grant_id><funding_grant_id>24A310023</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Zhao N</pubmed_authors><pubmed_authors>Sun M</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Chen K</pubmed_authors><pubmed_authors>Liang Y</pubmed_authors><pubmed_authors>Tabish MS</pubmed_authors><pubmed_authors>Shu J</pubmed_authors><pubmed_authors>Yang C</pubmed_authors><pubmed_authors>Sun Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>NDC80 promotes epithelial to mesenchymal transition of esophageal squamous cell carcinoma through macrophages polarization and PI3K/AKT pathway activation.</name><description>&lt;h4>Objective&lt;/h4>Esophageal squamous cell carcinoma (ESCC) is a lethal malignancy with limited therapeutic options, primarily due to its aggressive metastatic behavior. This study aimed to elucidate the molecular drivers of ESCC metastasis by identifying a critical oncogene and investigate its functional mechanisms.&lt;h4>Methods&lt;/h4>Using integrated bioinformatics screening, we identified NDC80 as a potential regulator of metastasis. The role and underlying mechanisms of NDC80 in ESCC progression have remained to be fully elucidated. We conducted in vitro functional assays-including real-time PCR, western blotting, and flow cytometry-to assess the effects of NDC80 on epithelial-mesenchymal transition (EMT) and malignant behavior. Mechanistic studies such as co-culture systems and ELISA, wer</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-05-16T03:17:35.391Z</modification><creation>2026-05-16T03:12:36.753Z</creation></dates><accession>S-EPMC12599082</accession><cross_references><pubmed>41207896</pubmed><doi>10.1186/s40001-025-03397-3</doi></cross_references></HashMap>